Abstract
Introduction

25
There are no disease-modifying osteoarthritis (OA) drugs available for treating knee OA at 26 present, and symptom-modifying therapy is the only available treatment for knee OA [1] [2] [3] .
27
Despite the importance of the symptoms of the disease, much remains unknown regarding the 28 nature, causes and natural history of OA symptoms.
29
Pain is the most prominent and disabling symptom of knee OA [4, 5] . Because
30
OA-associated joint damage may be associated with clinical problems, the joint damage 31 associated with the pain and the pathogenesis of pain must be investigated [6] . However, the 32 severity of joint disease is only weakly related to the clinical findings according to classic 33 radiographic techniques [2] .
34
Although OA was considered to be a non-inflammatory condition, the role of synovitis in
35
OA has attracted particular attention [7, 8] . It was recently reported that synovial 36 inflammation could play an important role in the pathophysiology of OA [9] [10] [11] [12] [13] . Synovitis in
37
OA may be a secondary phenomenon related to the cartilage alterations induced by the release 38 of degenerative compounds from the extracellular matrix of articular cartilage in response to 39 the presence of microcrystals in the synovial fluid and in the synovium [11, 14] . However, 40 most of the previous studies focused on synovitis in OA were conducted on patients with 41 early-to advanced-stage knee OA.
42
We previously revealed that the symptoms of patients with end-stage knee OA who required 43 5 total knee arthroplasty (TKA) showed a significant correlation with the severity of synovitis 44 in the affected knee joint [15] . On the other hand, no joint structural changes evaluated by 45 classic radiography were associated with the pain and symptoms of these patients. In addition,
46
it has remained unclear whether synovitis is also related to cartilage alterations or other 47 features in patients with end-stage knee OA, where the articular cartilage has been nearly lost.
48
We also previously reported that the cytokine profiles of the synovium in patients with 49 end-stage knee OA were different from those in patients with early-stage knee OA [13] .
50
The interest in developing other treatments for OA has stimulated the search for more 51 sensitive indicators of OA for use in conjunction with the traditional radiographic outcomes.
52
Magnetic resonance imaging (MRI) measurements, in addition to biomarkers, have sufficient 53 sensitivity to detect OA-related structural changes [16, 17] . MRI is currently being optimized
54
for OA imaging and is more sensitive than radiographic techniques to detect bone and soft 55 tissue changes, which are features of OA [18] . MRI can also provide a wealth of information 56 on the pathology of knee OA, its natural history and the structure-pain relationships, which is 57 not obtainable using radiography [19] . The semi-quantitative whole-organ MRI scoring
58
(WORMS) method offers an initial instrument for performing multi-feature assessments of 59 the knee using conventional MRI [20] .
60
The aim of our present study was to investigate whether the MRI-detected structural changes 
65
Subjects
66
Forty patients who fulfilled the American College of Rheumatology criteria for knee OA
67
[21] and who received TKA were enrolled in this study. This study was approved by the 68 institutional ethical review committee of our university. Written informed consent was 69 obtained from all participating patients.
71
Clinical manifestations
72
The clinical manifestations were evaluated using the Japanese Knee Osteoarthritis Measure
73
(JKOM) score [22] and the pain was evaluated using the visual analog scale (VAS, 0-100).
74
The JKOM is a patient-based, self-answered evaluation score that includes four subcategories: 
105
The intra-observer reproducibility (AY) of the MRI evaluation of OA was measured at 
164
The cumulative staining scores were calculated by summing the mean score of these four 165 parameters for each case.
166
The intra-observer reproducibility (AY) of the histological scores was measured at separate 
180
Patient characteristics
181
The characteristics of the patients in the present study are shown in Table (Table 3) . Similarly, neither synovial COX-2 expression levels nor synovial 197 IL-6 expression levels were associated with the HSSs of the patients (Table 3) 
229
We previously reported that the factors associated with the pain severity in patients with 230 knee OA varied with the radiographic disease severity [33] . The serum levels of IL-6, which 231 is related to synovitis, were mainly associated with the pain severity in early-stage knee OA,
232
while the anatomical axis angle, which represents the detrimental mechanical loading across 233 the joint, was mainly associated with that in advanced-to end-stage knee OA.
234
As the expression of COX-2, IL-1β and IL-6 in synovial tissues is thought to be activated by 235 degenerated articular cartilage, the expression of these inflammatory mediators would be 236 expected to be enhanced in the synovial tissues dependent on the severity of the disease.
237
However, the expression levels of these cytokines in patients with end-stage knee OA were 
271
There were several limitations associated with the current study. As the present study is Table 1 418
The characteristics of the patients in this study 
425
